{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:13:31Z","timestamp":1792844011758,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.clml.2026.01.002","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T07:34:25Z","timestamp":1768203265000},"page":"e557-e568.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Improvement in Cardiac Magnetic Resonance Parameters in Patients With Cardiac Light-Chain Amyloidosis Receiving Anticlonal Cell Therapy"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5740-9670","authenticated-orcid":false,"given":"Alexandros","family":"Briasoulis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Lama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelos","family":"Soranidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Georgiopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafail","family":"Patras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foteini","family":"Theodorakakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos-Iason","family":"Tepetes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meletios Athanasios","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Kelekis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimon","family":"Stamatelopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathios","family":"Kastritis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.clml.2026.01.002_bib0001","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s11886-022-01703-7","article-title":"Imaging-guided treatment for cardiac amyloidosis","volume":"24","author":"Ioannou","year":"2022","journal-title":"Curr Cardiol Rep"},{"issue":"4","key":"10.1016\/j.clml.2026.01.002_bib0002","first-page":"467","article-title":"AL amyloidosis: current chemotherapy and Immune therapy treatment strategies: JACC: cardio oncology state-of-the-art review","volume":"3","author":"Bianchi","year":"2021","journal-title":"JACC: CardioOncology"},{"issue":"36","key":"10.1016\/j.clml.2026.01.002_bib0003","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1200\/JCO.2011.37.7614","article-title":"New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes","volume":"30","author":"Palladini","year":"2012","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clml.2026.01.002_bib0004","first-page":"155","article-title":"Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis","volume":"3","author":"Syed","year":"2010","journal-title":"JACC: Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.clml.2026.01.002_bib0005","first-page":"256","article-title":"Invasive and non-Invasive diagnostic pathways in the diagnosis of cardiac amyloidosis","volume":"10","author":"Briasoulis","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"issue":"11","key":"10.1016\/j.clml.2026.01.002_bib0006","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1001\/jamacardio.2024.2555","article-title":"Redefining cardiac involvement and targets of treatment in systemic immunoglobulin AL amyloidosis","volume":"9","author":"Porcari","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"9","key":"10.1016\/j.clml.2026.01.002_bib0007","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/jamacardio.2023.2010","article-title":"Tracking treatment response in cardiac light-chain amyloidosis with native T1 mapping","volume":"8","author":"Ioannou","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"17","key":"10.1016\/j.clml.2026.01.002_bib0008","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1182\/blood-2012-12-473066","article-title":"A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis","volume":"121","author":"Wechalekar","year":"2013","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.clml.2026.01.002_bib0009","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1200\/JCO.2004.03.029","article-title":"Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis","volume":"22","author":"Dispenzieri","year":"2004","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.clml.2026.01.002_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41408-020-00355-6","article-title":"Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy","volume":"10","author":"Milani","year":"2020","journal-title":"Blood Cancer J"},{"issue":"Supplement 1","key":"10.1016\/j.clml.2026.01.002_bib0011","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1182\/blood-2021-149222","article-title":"Graded cardiac response criteria for AL amyloidosis: the impact of depth of cardiac response on survival","volume":"138","author":"Muchtar","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clml.2026.01.002_bib0012","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13244-022-01194-8","article-title":"The utility of splenic imaging parameters in cardiac magnetic resonance for the diagnosis of immunoglobulin light-chain amyloidosis","volume":"13","author":"Lama","year":"2022","journal-title":"Insights Imaging"},{"issue":"5","key":"10.1016\/j.clml.2026.01.002_bib0013","first-page":"810","article-title":"Native T1 and extracellular volume in transthyretin amyloidosis","volume":"12","author":"Ana","year":"2019","journal-title":"JACC: Cardiovascular Imaging"},{"issue":"45","key":"10.1016\/j.clml.2026.01.002_bib0014","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1093\/eurheartj\/ehac363","article-title":"Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment","volume":"43","author":"Martinez-Naharro","year":"2022","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.clml.2026.01.002_bib0015","article-title":"Cardiac amyloidosis: multimodal imaging of disease activity and response to treatment","volume":"14","author":"Patel","year":"2021","journal-title":"Cir Cardiovasc Imaging"},{"issue":"14","key":"10.1016\/j.clml.2026.01.002_bib0016","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/heartjnl-2016-310704","article-title":"Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response","volume":"103","author":"Grogan","year":"2017","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.clml.2026.01.002_bib0017","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/ehjci\/jead351","article-title":"Left ventricular myocardial work improves in response to treatment and is associated with survival among patients with light chain cardiac amyloidosis","volume":"25","author":"Briasoulis","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.clml.2026.01.002_bib0018","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/eurheartj\/ehu444","article-title":"T1 mapping and survival in systemic light-chain amyloidosis","volume":"36","author":"Banypersad","year":"2015","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.clml.2026.01.002_bib0019","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1002\/jmri.27459","article-title":"Reference ranges, diagnostic and prognostic utility of native T1 mapping and extracellular volume for cardiac amyloidosis: a meta-analysis","volume":"53","author":"Wang","year":"2021","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"10.1016\/j.clml.2026.01.002_bib0020","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oead092","article-title":"Prognosis prediction in cardiac amyloidosis by cardiac magnetic resonance imaging: a systematic review with meta-analysis","volume":"3","author":"Boretto","year":"2023","journal-title":"Eur Heart J Open"},{"issue":"8","key":"10.1016\/j.clml.2026.01.002_bib0021","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3324\/haematol.2008.004119","article-title":"Histological regression of amyloid in AL amyloidosis is exclusively seen after normalization of serum free light chain","volume":"94","author":"Van Gameren","year":"2009","journal-title":"Haematologica"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265026000066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265026000066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T03:16:57Z","timestamp":1776741417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265026000066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2152265026000066"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2026.01.002","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvement in Cardiac Magnetic Resonance Parameters in Patients With Cardiac Light-Chain Amyloidosis Receiving Anticlonal Cell Therapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2026.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}